NSC faces rising costs, weak liquidity and tariff pressures, with falling estimates and share declines underscoring mounting investor concerns.

BLSH's third-quarter performance is expected to have benefited from strong subscription gains and momentum across Liquidity Services and CoinDesk products.

SCOTTSDALE, Ariz. , Nov. 17, 2025 /PRNewswire/ -- The holidays can feel like a full-contact sport for your back.

MARLBOROUGH, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) -- ConnectM Technology Solutions, Inc. (OTC: CNTM) (“ConnectM” or the “Company”), a constellation of technology-driven businesses powering the modern energy economy, today reported financial results for the three and nine months ended September 30, 2025, following the Company's filing of its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission on November 17, 2025.

Warner Bros is continuing its partnership with “shared reality” venue operator Cosm, slating a new version of Harry Potter and the Sorcerer's Stone for 2026. The date of the Cosm run has not been revealed. Tickets will go on sale in “early 2026,” the companies said Monday.

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

AIRT revenues dip in second-quarter fiscal 2026, but profitability surges as margin gains and asset sales offset weaker segment performance.

GLW's gains trail industry highs, but rising AI data-center demand and strong specialty materials momentum sharpen its growth story.

CIFR's 209% YTD rally and major HPC deals stand out, but rising costs and valuation concerns remain a headwind.

Medical Properties Trust, Inc. is controversial and has mixed fundamentals with a new, surprising move to the dividend. MPW's management suggests confidence in future cash flows. Despite a Q3 earnings miss and elevated net debt, portfolio restructuring and strong rent collections indicate operational progress.

NeurAxis posts its fifth straight quarter of double-digit expansion, but rising costs and margin pressure weigh on third-quarter 2025 results.

CRWS' earnings increase in second-quarter fiscal 2026 despite lower sales and tariff pressures, fueled by cost cuts and strong toy demand.

Northrim BanCorp (NRIM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Astronics Corporation (ATRO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Aris Mining Corporation (ARMN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

The foot is still firmly on the gas when looking at the next few years of “AI” within large-cap tech, communication services and consumer discretionary. The one red flag that is waving is that after +25% returns for the S&P 500 in 2023 and 2024 and now a YTD return for the benchmark as of 11/15/25 of +15.65%, usually the 4th year is low-single-digits or negative. 2026 could be a tougher year, even with the expected 14% EPS growth rate next year, although this blog said the same thing at roughly the same time last year.

Datavault AI Inc. (NASDAQ: DVLT) shares climbed Monday after the company reported strong quarterly earnings and a bold increase in its financial guidance for 2025 and 2026.

CNS Pharmaceuticals, Inc. ( CNSP ) Shareholder/Analyst Call November 17, 2025 12:00 PM EST Company Participants John Climaco - CEO, President & Director Christopher Downs - Chief Financial Officer Presentation John Climaco CEO, President & Director Welcome, everyone. The Annual Meeting of the Stockholders of CNS Pharmaceuticals, Inc. is hereby convened and called to order.

Johnson & Johnson ( JNJ ) 7th Annual Wolfe Research Healthcare Conference November 17, 2025 10:40 AM EST Company Participants Candice Long - Worldwide Vice President of Immunology David Lee - Global Therapeutic Area Head, Immunology for Janssen Pharmaceutical Conference Call Participants Alexandria Hammond - Wolfe Research, LLC Presentation Alexandria Hammond Wolfe Research, LLC Good morning, everybody. My name is Alex Hammond, and I'm the biopharma analyst here at Wolfe.

BeOne Medicines AG ( ONC ) Jefferies London Healthcare Conference 2025 November 17, 2025 11:00 AM EST Company Participants John Oyler - Co-Founder, Executive Chairman & CEO Aaron Rosenberg - Chief Financial Officer Mark Lanasa - Senior VP & Chief Medical Officer for Solid Tumors Conference Call Participants Yuxi Dong - Jefferies LLC, Research Division Presentation Yuxi Dong Jefferies LLC, Research Division All right. Good afternoon, everyone.